Trimedyne, Inc. reported financial results for the quarter and nine-month period ended June 30, 2016. Revenues for the current quarter were $1,106,000, a decrease of 25% from revenues of $1,482,000 for the prior year's quarter. The decrease in Revenue was primarily due to a decrease in sales of Lasers and accessories compared to the prior year period. The Company had a net loss of $97,000 or $0.01 per share for the current quarter, compared to a net loss of $123,000 or $0.01 per share for the prior year quarter. For the nine-month period ended June 30, 2016, revenues were $3,776,000, a decrease of 6% from $4,027,000 for the same period of 2015. For the nine months ended June 30, 2016, the Company's net loss was $469,000 or $0.03 per share, compared to a net loss of $466,000 or $0.03 per share for the same nine-month period of 2015.